Finance

Lists
Why is OBI down 4.40%?
Dive Deeper
OBI:LON
Ondine Biomedical Inc
GBX 8.70
-4.40%
(-0.40) 1D
Nov 13, 4:30:00 PM UTC  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OBI...
Open
GBX 8.80
High
GBX 9.20
Low
GBX 8.70
Mkt. cap
58.51M
Avg. vol.
342.34K
Volume
537.99K
52-wk high
GBX 15.50
52-wk low
GBX 7.50
EPS
-GBX 0.03
No. of employees
43
Open
GBX 8.80
High
GBX 9.20
Low
GBX 8.70
Mkt. cap
58.51M
Avg. vol.
342.34K
Volume
537.99K
52-wk high
GBX 15.50
52-wk low
GBX 7.50
EPS
-GBX 0.03
No. of employees
43
News stories
From web sources and news partners
About Ondine Biomedical Inc
CEO-
Employees43
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorHealth Care
IndustryMedical device
Websiteondinebio.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
816.50K
816.50K
622.50K
622.50K
Cost of goods sold
339.00K
339.00K
217.00K
217.00K
Cost of revenue
339.00K
339.00K
217.00K
217.00K
Research and development expenses
6.63M
6.63M
5.74M
5.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.45M
2.45M
2.50M
2.50M
Operating expense
9.20M
9.20M
8.36M
8.36M
Total operating expenses
9.54M
9.54M
8.58M
8.58M
Operating income
-8.72M
-8.72M
-7.96M
-7.96M
Other non operating income
26.50K
26.50K
-
-
EBT including unusual items
-8.48M
-8.48M
-8.08M
-8.08M
EBT excluding unusual items
-8.48M
-8.48M
-8.08M
-8.08M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.48M
-8.48M
-8.08M
-8.08M
Net profit margin
-1,038.46%
-1,038.46%
-1,297.91%
-1,297.91%
Earnings per share
-
-
-
-
Interest and investment income
90.00K
90.00K
28.00K
28.00K
Interest expense
-9.00K
-9.00K
-6.00K
-6.00K
Net interest expenses
81.00K
81.00K
22.00K
22.00K
Depreciation and amortization charges
120.00K
120.00K
126.00K
126.00K
EBITDA
-8.63M
-8.66M
-7.89M
-7.89M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps